61/592/2026 - Medicamento Bevacizumab 400 mg/16 ml Sol inj Fr 16 ml IV

ID 13621537 · Portal BASE
Price
Base Price
€39,960 .00
Effective Price
€39,960 .00 0.0%
Contract Details
Contract Type
Aquisição de bens móveis
Procedure
Ajuste Direto Regime Geral
CPV Code
33690000
Location
Portugal, Faro
Bidder Count
—
Winner
AMGEN-BIO-FARMACÊUTICA LDA
NIF 502942959
Company
Dates
Publication
24 Feb 2026
Celebration
14 Jan 2026
Contracting Entity
Centro Hospitalar Universitário do Algarve, EPE
NIF 510745997
Public body
Data Source
Portal BASE
Api · synced 2026-04-17
Risk Flags
Score 40 · MEDIUM RISK
A2 · Late Publication
A2_PUBLICATION_AFTER_CELEBRATION
HIGH
Publication Date
24 Feb 2026
Signing Date
14 Jan 2026
Days Late
41
Rule
A2/A3 late publication: 41 days after signing (threshold: 10)
Detected 2026-03-06